Ofatumumab
CD20-directed Cytolytic Antibody
Ofatumumab Pen Injector
| Dosage | Brand | Image |
|---|---|---|
| 0.4 ML ofatumumab 50 MG/ML Pen Injector | Generic | |
| 0.4 ML ofatumumab 50 MG/ML Pen Injector [Kesimpta] | Generic |
Ofatumumab Injection
| Dosage | Brand | Image |
|---|---|---|
| 5 ML ofatumumab 20 MG/ML Injection | Generic | |
| 5 ML ofatumumab 20 MG/ML Injection [Arzerra] | Generic | |
| 50 ML ofatumumab 20 MG/ML Injection | Generic | |
| 50 ML ofatumumab 20 MG/ML Injection [Arzerra] | Generic |
Ofatumumab drug classes:
- CD20-directed Cytolytic Antibody
Ofatumumab pharmacologic actions:
- Antineoplastic Agents
Ofatumumab mechanism of action:
- CD20-directed Antibody Interactions
